Scientists have developed a new mRNA vaccine to treat pancreatic cancer that may extend patients' lifespans by 8 to 10 years.

Researchers at Oregon Health & Science University have developed a new blood test that they say is able to detect pancreatic ...

A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...

The following is a summary of “Bio-artificial pancreas to treat type 1 diabetes: Perspectives from healthcare professionals ...

A new blood-based test could diagnose pancreatic cancer much earlier, improving outcomes for people with the disease.

Pancreatic cancer (PC) is the worst prognosis cancer globally, with just 13% of patients who are diagnosed with PC surviving for 5 years or more after initial diagnosis. Early detection of PC is the ...

The discovery of a 'biomarker panel' could have a profound impact on the ability to identify patients at risk of developing ...

Pancreatic cancer is fueled by connections to the nervous system. This is reported by scientists from the German Cancer ...

An artificial pancreas combines a glucose monitor with an insulin pump. In this video, Griffin Rodgers, MD, director of ...